Viewing Study NCT00866359


Ignite Creation Date: 2025-12-24 @ 2:47 PM
Ignite Modification Date: 2026-02-02 @ 2:17 PM
Study NCT ID: NCT00866359
Status: COMPLETED
Last Update Posted: 2020-06-19
First Post: 2009-03-18
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: A Study to Evaluate the Efficacy and Safety of Apremilast (CC-10004) in the Treatment of Behçet Disease
Sponsor: Amgen
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: CC-10004-BCT-001
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators